Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

945
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
945
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

690
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
690
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

428
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
428
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

846
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
846
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

611
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
611
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

866
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
866

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross-Sectional Analysis From the VOLTAIRE Study.

Diabetes, obesity & metabolism·2026
Same author

Time as the language of behavior: Events, sequences, patterns and meanings.

Journal of neuroscience methods·2026
Same author

Thalamic 5-HT<sub>2A</sub> receptor activation reduces GABA uptake, increases tonic GABA<sub>A</sub> inhibition and induces absence seizures in Wistar rats.

Neuropharmacology·2026
Same author

Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study.

Clinical cardiology·2026
Same author

Syndecan-1, endocan and non-culprit coronary plaque composition following non-ST elevation myocardial infarction.

International journal of cardiology. Heart & vasculature·2026
Same author

Developmental and cell type-specific contributions of thalamic serotonin 2A receptors to absence seizures.

Epilepsia·2026

Related Experiment Video

Updated: Nov 18, 2025

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.3K

5-HT/GABA interaction in epilepsy.

Gabriele Deidda1, Vincenzo Crunelli2, Giuseppe Di Giovanni2

  • 1Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.

Progress in Brain Research
|February 5, 2021
PubMed
Summary

Serotonin plays a role in modulating epilepsy, potentially by interacting with GABA. This offers new therapeutic targets for drug-resistant epilepsy cases.

Keywords:
5-HT5-HT receptorsGABAGABA(A) receptorsepilepsy

More Related Videos

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

17.7K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

602

Related Experiment Videos

Last Updated: Nov 18, 2025

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.3K
Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

17.7K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

602

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Epilepsy is a neurological disorder marked by seizures, which are synchronous neuronal oscillations.
  • Current treatments primarily target GABA, but some patients remain drug-resistant, necessitating novel therapeutic strategies.
  • Serotonin is an identified neurotransmitter implicated in epilepsy, suggesting its potential as a therapeutic target.

Purpose of the Study:

  • To review preclinical and human evidence on serotonin's role in epilepsy.
  • To explore the mechanisms by which serotonin modulates epileptic activity.
  • To highlight serotonin's potential as a therapeutic target for drug-resistant epilepsy.

Main Methods:

  • Literature review of preclinical studies.
  • Analysis of human evidence regarding serotonin and epilepsy.
  • Examination of the interaction between serotonin and GABAergic systems in epilepsy.

Main Results:

  • Evidence indicates that serotonin significantly modulates epileptic seizures.
  • Serotonin's effect on epilepsy appears to be mediated through substantial modulation or interaction with the GABA system.
  • This interaction suggests a key pathway for serotonin's influence on neuronal excitability.

Conclusions:

  • Serotonin is a key modulator of epilepsy, with significant implications for treatment.
  • The interaction between serotonin and GABA is a critical mechanism in controlling epileptic activity.
  • Targeting the serotonin-GABA axis presents a promising avenue for developing new therapies for pharmacoresistant epilepsy.